1. A dietary mixture containing fish oil, resveratrol, lycopene, catechins, and vitamins E and C reduces atherosclerosis in transgenic mice.
- Author
-
Verschuren L, Wielinga PY, van Duyvenvoorde W, Tijani S, Toet K, van Ommen B, Kooistra T, and Kleemann R
- Subjects
- Acute-Phase Proteins analysis, Animals, Antioxidants administration & dosage, Apolipoprotein E3 genetics, Ascorbic Acid administration & dosage, Ascorbic Acid therapeutic use, Atherosclerosis blood, Atherosclerosis epidemiology, Atherosclerosis pathology, Biomarkers blood, C-Reactive Protein analysis, C-Reactive Protein genetics, Carotenoids administration & dosage, Carotenoids therapeutic use, Catechin administration & dosage, Catechin therapeutic use, Female, Fish Oils administration & dosage, Humans, Lycopene, Male, Mice, Mice, Transgenic, Resveratrol, Risk Factors, Stilbenes administration & dosage, Stilbenes therapeutic use, Vitamin E administration & dosage, Vitamin E therapeutic use, Antioxidants therapeutic use, Atherosclerosis diet therapy, Diet, Fish Oils therapeutic use
- Abstract
Chronic inflammation and proatherogenic lipids are important risk factors of cardiovascular disease (CVD). Specific dietary constituents such as polyphenols and fish oils may improve cardiovascular risk factors and may have a beneficial effect on disease outcomes. We hypothesized that the intake of an antiinflammatory dietary mixture (AIDM) containing resveratrol, lycopene, catechin, vitamins E and C, and fish oil would reduce inflammatory risk factors, proatherogenic lipids, and endpoint atherosclerosis. AIDM was evaluated in an inflammation model, male human C-reactive protein (CRP) transgenic mice, and an atherosclerosis model, female ApoE*3Leiden transgenic mice. Two groups of male human-CRP transgenic mice were fed AIDM [0.567% (wt:wt) powder and 0.933% (wt:wt oil)] or placebo for 6 wk. The effects of AIDM on basal and IL-1β-stimulated CRP expression were investigated. AIDM reduced cytokine-induced human CRP and fibrinogen expression in human-CRP transgenic mice. In the atherosclerosis study, 2 groups of female ApoE*3Leiden transgenic mice were fed an atherogenic diet supplemented with AIDM [0.567% (wt:wt) powder and 0.933% (wt:wt oil)] or placebo for 16 wk. AIDM strongly reduced plasma cholesterol, TG, and serum amyloid A concentrations compared with placebo. Importantly, long-term treatment of ApoE*3Leiden mice with AIDM markedly reduced the development of atherosclerosis by 96% compared with placebo. The effect on atherosclerosis was paralleled by a reduced expression of the vascular inflammation markers and adhesion molecules inter-cellular adhesion molecule-1 and E-selectin. Dietary supplementation of AIDM improves lipid and inflammatory risk factors of CVD and strongly reduces atherosclerotic lesion development in female transgenic mice.
- Published
- 2011
- Full Text
- View/download PDF